Source: Web Search Revision Year: 2025 Publisher: GlaxoSmithKline Pte Ltd, 23 Rochester Park, Singapore 139234
MAREVAN.
| Pharmaceutical Form |
|---|
|
Warfarin sodium, 1 mg, tablet: Brown round flat bevelled edge tablets engraved DF/M1 Warfarin sodium, 3 mg, tablet: Pale blue round flat bevelled edge tablets engraved DF/M3 Warfarin sodium, 5 mg, tablet: Pink round flat bevelled edge tablets engraved DF/M5 |
Warfarin sodium as 1 mg, 3 mg and 5 mg tablets.
Warfarin sodium, 1 mg, tablet: Each tablet contains 1 mg of warfarin sodium.
Warfarin sodium, 3 mg, tablet: Each tablet contains 3 mg of warfarin sodium.
Warfarin sodium, 5 mg, tablet: Each tablet contains 5 mg of warfarin sodium.
| Active Ingredient |
|---|
|
Warfarin is a synthetic 4-Hydroxycoumarin derivative which acts by preventing the formation of active procoagulation factors II, VII, IX and X in the liver by inhibiting the vitamin K - mediated gammacarboxylation of precursor proteins. Full therapeutic activity is not achieved until circulating coagulation factors have been removed by normal catabolism. This occurs at different rates for each factor, with factor VII having the shortest half-life. Warfarin has no direct thrombolytic effect, though it may limit the extension of existing thrombi. |
| List of Excipients |
|---|
|
|
GlaxoSmithKline Pte Ltd, 23 Rochester Park, Singapore 139234
| Drug | Countries | |
|---|---|---|
| MAREVAN | Australia, Brazil, Estonia, Finland, New Zealand, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.